| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | ISO | RGD:737222 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of CYP17A1 mRNA | CTD | PMID:11509743 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:737222 | 6480464 | [Estradiol co-treated with 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane] results in decreased expression of CYP17A1 mRNA | CTD | PMID:11509743 |
| 1,3-dinitrobenzene | decreases expression | ISO | RGD:1350540 | 6480464 | 3-dinitrobenzene results in decreased expression of CYP17A1 mRNA | CTD | PMID:22841810 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1350540 | 6480464 | [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein | CTD | PMID:17418832 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:12655037 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:15901920 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:15901920 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:15834898 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:737222 | 6480464 | Ethinyl Estradiol results in increased expression of CYP17A1 mRNA | CTD | PMID:12072388 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:737222 | 6480464 | Ethinyl Estradiol affects the expression of CYP17A1 mRNA | CTD | PMID:14976129 |
| 17alpha-hydroxypregnenolone | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxypregnenolone | CTD | PMID:16030167 |
| 17alpha-hydroxypregnenolone | decreases acetylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in decreased acetylation of 17-alpha-Hydroxypregnenolone | CTD | PMID:15562394 |
| 17alpha-hydroxypregnenolone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of 17-alpha-Hydroxypregnenolone | CTD | PMID:16030167 |
| 17alpha-hydroxyprogesterone | affects abundance | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the abundance of 17-alpha-Hydroxyprogesterone | CTD | PMID:21427057 |
| 17alpha-hydroxyprogesterone | multiple interactions | ISO | RGD:1350540 | 6480464 | TNF protein inhibits the reaction [CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone] | CTD | PMID:16030167 |
| 17alpha-hydroxyprogesterone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of 17-alpha-Hydroxyprogesterone | CTD | PMID:16030167 |
| 17alpha-hydroxyprogesterone | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of 17-alpha-Hydroxyprogesterone | CTD | PMID:16030167 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737222 | 6480464 | ESR1 protein affects the reaction [Estradiol results in decreased expression of CYP17A1 mRNA] | CTD | PMID:17158782 |
| 17beta-estradiol | increases expression | ISO | RGD:737222 | 6480464 | Estradiol results in increased expression of CYP17A1 mRNA | CTD | PMID:18281260 |
| 17beta-estradiol | decreases expression | ISO | RGD:737222 | 6480464 | Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:11509743 PMID:17158782 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:20144698 |
| 17beta-estradiol | decreases expression | ISO | RGD:737222 | 6480464 | Estradiol results in decreased expression of CYP17A1 mRNA | CTD | PMID:17158782 PMID:11509743 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737222 | 6480464 | [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:11509743 |
| 1H-pyrazole | decreases expression | ISO | RGD:737222 | 6480464 | pyrazole results in decreased expression of CYP17A1 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Gonadotropins, Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA] | CTD | PMID:19276399 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737222 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:16254025 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP17A1 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:16254025 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:16254025 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP17A1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737222 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:17291543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:16254025 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19276399 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 protein | CTD | PMID:19276399 PMID:17291543 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19276399 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19490992 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737222 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 mRNA | CTD | PMID:19490992 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP17A1 protein | CTD | PMID:17291543 PMID:19276399 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CYP17A1 mRNA | CTD | PMID:21346803 |
| 2,6-dibromophenol | decreases expression | ISO | RGD:1350540 | 6480464 | 2,6-dibromophenol results in decreased expression of CYP17A1 mRNA | CTD | PMID:17447562 |
| 2-methoxyethanol | decreases expression | EXP | | 6480464 | methyl cellosolve results in decreased expression of CYP17A1 mRNA | CTD | PMID:21061450 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] | CTD | PMID:21918126 |
| 2-trans,6-trans-farnesyl diphosphate | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] | CTD | PMID:21918126 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases activity | ISO | RGD:1350540 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP17A1 protein | CTD | PMID:15703266 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP17A1 mRNA | CTD | PMID:20959002 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:1350540 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP17A1 mRNA | CTD | PMID:16216300 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:1350540 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYP17A1 mRNA | CTD | PMID:15703266 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:737222 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP17A1 mRNA | CTD | PMID:12781204 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:737222 | 6480464 | 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; more ... | CTD | PMID:21726595 |
| 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol | decreases expression | ISO | RGD:1350540 | 6480464 | 1H,1H,2H,2H-perfluorodecanol results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:20615422 |
| 3alpha-hydroxy-5beta-pregnan-20-one | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in increased hydroxylation of Pregnanolone analog | CTD | PMID:14522586 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of CYP17A1 mRNA | CTD | PMID:19162173 |
| 5alpha-pregnane-3,20-dione | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in increased hydroxylation of 5-alpha-Dihydroprogesterone | CTD | PMID:14522586 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:737222 | 6480464 | 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]; more ... | CTD | PMID:21726595 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1350540 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA | CTD | PMID:22079614 PMID:22546480 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1350540 | 6480464 | Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] | CTD | PMID:22546480 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1350540 | 6480464 | [4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein | CTD | PMID:18336853 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:737222 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA; more ... | CTD | PMID:21726595 |
| acetaldehyde | multiple interactions | ISO | RGD:737222 | 6480464 | [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of CYP17A1 mRNA | CTD | PMID:22285649 |
| aflatoxin B1 | decreases expression | ISO | RGD:737222 | 6480464 | Aflatoxin B1 results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 |
| albuterol | increases expression | ISO | RGD:1350540 | 6480464 | Albuterol results in increased expression of CYP17A1 | CTD | PMID:17822730 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1350540 | 6480464 | Tretinoin results in increased expression of CYP17A1 mRNA | CTD | PMID:16621909 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:737222 | 6480464 | Tretinoin inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP17A1 mRNA] | CTD | PMID:22285649 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CYP17A1 mRNA | CTD | PMID:14960491 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP17A1 mRNA | CTD | PMID:16483693 |
| andrographolide | multiple interactions | ISO | RGD:737222 | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA | CTD | PMID:19737545 |
| androst-4-ene-3,17-dione | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androstenedione | CTD | PMID:15562394 more ... |
| androst-4-ene-3,17-dione | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androstenedione | CTD | PMID:15562394 more ... |
| androst-4-ene-3,17-dione | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androstenedione | CTD | PMID:16030167 more ... |
| androst-4-ene-3,17-dione | affects chemical synthesis | ISO | RGD:737222 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androstenedione | CTD | PMID:15555913 |
| androst-4-ene-3,17-dione | multiple interactions | ISO | RGD:1350540 | 6480464 | TNF protein inhibits the reaction [CYP17A1 protein affects the chemical synthesis of Androstenedione] | CTD | PMID:16030167 |
| androst-4-ene-3,17-dione | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androstenedione | CTD | PMID:14522586 more ... |
| androst-4-ene-3,17-dione | affects abundance | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the abundance of Androstenedione | CTD | PMID:21427057 |
| androst-4-ene-3,17-dione | decreases expression | ISO | RGD:1350540 | 6480464 | Androstenedione results in decreased expression of CYP17A1 mRNA | CTD | PMID:15625562 |
| androsterone | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Androsterone | CTD | PMID:14522586 |
| arsenic atom | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of Arsenic | CTD | PMID:18682255 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP17A1 protein; more ... | CTD | PMID:20667998 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of CYP17A1 mRNA | CTD | PMID:20667998 PMID:23200735 |
| atrazine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA; more ... | CTD | PMID:23200735 |
| atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of CYP17A1 mRNA | CTD | PMID:19541795 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737222 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of CYP17A1 mRNA | CTD | PMID:22960446 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CYP17A1 protein; more ... | CTD | PMID:21737371 |
| bisphenol A | decreases expression | ISO | RGD:737222 | 6480464 | bisphenol A results in decreased expression of CYP17A1 mRNA | CTD | PMID:21182934 |
| bisphenol A | decreases activity | EXP | | 6480464 | bisphenol A results in decreased activity of CYP17A1 protein | CTD | PMID:21925253 |
| bisphenol A | decreases activity | ISO | RGD:1350540 | 6480464 | bisphenol A results in decreased activity of CYP17A1 protein | CTD | PMID:21427057 PMID:21925253 |
| bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A results in increased expression of CYP17A1 mRNA] which affects the abundance of Testosterone | CTD | PMID:18191889 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP17A1 mRNA | CTD | PMID:18191889 |
| bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone | CTD | PMID:14605012 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP17A1 protein | CTD | PMID:20144698 PMID:14605012 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP17A1 mRNA | CTD | PMID:15901920 PMID:20144698 |
| bisphenol A | decreases activity | ISO | RGD:1350540 | 6480464 | bisphenol A results in decreased activity of CYP17A1 protein | CTD | PMID:21427057 |
| bisphenol A | increases expression | ISO | RGD:737222 | 6480464 | bisphenol A results in increased expression of CYP17A1 mRNA | CTD | PMID:17706920 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP17A1 protein | CTD | PMID:14605012 PMID:20144698 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP17A1 mRNA | CTD | PMID:20144698 PMID:15901920 |
| bucladesine | decreases expression | EXP | | 6480464 | Bucladesine results in decreased expression of CYP17A1 mRNA | CTD | PMID:21693180 |
| bucladesine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA; more ... | CTD | PMID:23200735 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of CYP17A1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | decreases expression | ISO | RGD:737222 | 6480464 | Cadmium Chloride results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:19897027 |
| carbamazepine | decreases activity | ISO | RGD:1350540 | 6480464 | Carbamazepine results in decreased activity of CYP17A1 protein | CTD | PMID:15730543 |
| carbamazepine | decreases expression | ISO | RGD:1350540 | 6480464 | Carbamazepine results in decreased expression of CYP17A1 mRNA | CTD | PMID:19566492 |
| cetrorelix | multiple interactions | ISO | RGD:1350540 | 6480464 | [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:18160741 |
| chloroquine | decreases expression | EXP | | 6480464 | Chloroquine results in decreased expression of CYP17A1 mRNA | CTD | PMID:19393257 |
| cholesterol | affects chemical synthesis | ISO | RGD:737222 | 6480464 | CYP17A1 protein affects the chemical synthesis of Cholesterol | CTD | PMID:15761033 |
| cinnamic acid | decreases activity | ISO | RGD:1350540 | 6480464 | cinnamic acid analog results in decreased activity of CYP17A1 protein | CTD | PMID:15072549 |
| cis-ketoconazole | decreases activity | ISO | RGD:1350540 | 6480464 | Ketoconazole results in decreased activity of CYP17A1 protein | CTD | PMID:15743198 PMID:15771425 |
| cis-ketoconazole | decreases activity | ISO | RGD:1350540 | 6480464 | Ketoconazole results in decreased activity of CYP17A1 protein | CTD | PMID:15771425 PMID:15743198 |
| cis-ketoconazole | decreases activity | EXP | | 6480464 | Ketoconazole results in decreased activity of CYP17A1 protein | CTD | PMID:15934942 |
| clofibrate | multiple interactions | ISO | RGD:737222 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of CYP17A1 mRNA | CTD | PMID:15033592 |
| clofibrate | decreases expression | ISO | RGD:737222 | 6480464 | Clofibrate results in decreased expression of CYP17A1 mRNA | CTD | PMID:17585979 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA | CTD | PMID:17602206 |
| cyanamide | multiple interactions | ISO | RGD:737222 | 6480464 | Cyanamide inhibits the reaction [CGA protein results in increased expression of CYP17A1 mRNA] | CTD | PMID:22285649 |
| cyclosporin A | decreases expression | ISO | RGD:737222 | 6480464 | Cyclosporine results in decreased expression of CYP17A1 mRNA | CTD | PMID:19770486 |
| cypermethrin | decreases expression | ISO | RGD:737222 | 6480464 | cypermethrin results in decreased expression of CYP17A1 mRNA | CTD | PMID:21397294 PMID:21560301 |
| dehydroepiandrosterone | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | CTD | PMID:15562394 PMID:16030167 |
| dehydroepiandrosterone | affects chemical synthesis | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | CTD | PMID:16030167 PMID:15562394 |
| dehydroepiandrosterone | affects metabolic processing | EXP | | 6480464 | CYP17A1 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:15261307 |
| dehydroepiandrosterone | affects chemical synthesis | ISO | RGD:737222 | 6480464 | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | CTD | PMID:15666818 |
| dehydroepiandrosterone | affects chemical synthesis | EXP | | 6480464 | CYP17A1 protein affects the chemical synthesis of Dehydroepiandrosterone | CTD | PMID:15934942 |
| dehydroepiandrosterone | decreases expression | ISO | RGD:1350540 | 6480464 | Dehydroepiandrosterone results in decreased expression of CYP17A1 mRNA | CTD | PMID:15625562 |
| desogestrel | multiple interactions | ISO | RGD:1350540 | 6480464 | [cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA | CTD | PMID:18160741 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA | CTD | PMID:22615892 |
| diarsenic trioxide | decreases expression | ISO | RGD:737222 | 6480464 | arsenic trioxide results in decreased expression of CYP17A1 mRNA | CTD | PMID:18630931 |
| dibutyl phthalate | multiple interactions | EXP | | 6480464 | Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP17A1 promoter]; more ... | CTD | PMID:17884934 |
| dibutyl phthalate | multiple interactions | EXP | | 6480464 | Dibutyl Phthalate inhibits the reaction [NR5A1 protein binds to CYP17A1 promoter] | CTD | PMID:23358192 |
| dibutyl phthalate | decreases expression | ISO | RGD:737222 | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:22511013 |
| dibutyl phthalate | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA | CTD | PMID:22615892 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:14617579 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:14617579 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:14617579 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:15987825 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:15141095 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:21266533 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 protein | CTD | PMID:14617579 PMID:15141095 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:14617579 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:21266533 more ... |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYP17A1 protein | CTD | PMID:15141095 PMID:14617579 |
| diethyl phthalate | multiple interactions | EXP | | 6480464 | diethyl phthalate inhibits the reaction [NR5A1 binds to CYP17A1 promoter] | CTD | PMID:17884934 |
| diethylstilbestrol | affects expression | ISO | RGD:737222 | 6480464 | Diethylstilbestrol affects the expression of CYP17A1 mRNA; more ... | CTD | PMID:15196701 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of CYP17A1 mRNA | CTD | PMID:22615892 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of CYP17A1 protein | CTD | PMID:9361775 |
| diheptyl phthalate | decreases expression | EXP | | 6480464 | diheptyl phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:22112501 |
| diisononyl phthalate | decreases expression | EXP | | 6480464 | diisononyl phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:22112501 |
| dipentyl phthalate | decreases activity | EXP | | 6480464 | di-n-pentyl phthalate results in decreased activity of CYP17A1 protein | CTD | PMID:6829050 |
| dipentyl phthalate | decreases expression | EXP | | 6480464 | di-n-pentyl phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:22112501 |
| disulfiram | multiple interactions | ISO | RGD:737222 | 6480464 | Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP17A1 mRNA] | CTD | PMID:22285649 |
| drospirenone | multiple interactions | ISO | RGD:1350540 | 6480464 | [Ethinyl Estradiol co-treated with drospirenone] results in decreased activity of CYP17A1 protein | CTD | PMID:17418832 |
| estrone | affects abundance | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the abundance of Estrone | CTD | PMID:21427057 |
| farnesyl diphosphate | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA] | CTD | PMID:21918126 |
| fenvalerate | decreases expression | ISO | RGD:737222 | 6480464 | fenvalerate results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:20138952 |
| fenvalerate | decreases expression | ISO | RGD:737222 | 6480464 | fenvalerate results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:20063364 PMID:20138952 |
| flutamide | increases expression | ISO | RGD:737222 | 6480464 | Flutamide results in increased expression of CYP17A1 mRNA | CTD | PMID:11509743 |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CYP17A1 mRNA | CTD | PMID:21525395 more ... |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CYP17A1 mRNA | CTD | PMID:21525395 more ... |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CYP17A1 mRNA | CTD | PMID:14967917 more ... |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CYP17A1 mRNA | CTD | PMID:21525395 PMID:14967917 |
| fulvestrant | increases expression | ISO | RGD:737222 | 6480464 | fulvestrant results in increased expression of CYP17A1 mRNA | CTD | PMID:17158782 |
| fumonisin B1 | decreases expression | ISO | RGD:737222 | 6480464 | fumonisin B1 results in decreased expression of CYP17A1 mRNA | CTD | PMID:16221962 |
| gamma-hexachlorocyclohexane | multiple interactions | ISO | RGD:1350540 | 6480464 | Lindane inhibits the reaction [Forskolin results in increased expression of CYP17A1 mRNA] | CTD | PMID:17080404 |
| geldanamycin | increases expression | ISO | RGD:737222 | 6480464 | geldanamycin results in increased expression of CYP17A1 mRNA | CTD | PMID:15711029 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CYP17A1 mRNA | CTD | PMID:15901920 |
| genistein | increases expression | ISO | RGD:737222 | 6480464 | Genistein results in increased expression of CYP17A1 mRNA | CTD | PMID:18281260 |
| genistein | decreases expression | ISO | RGD:737222 | 6480464 | Genistein results in decreased expression of CYP17A1 mRNA | CTD | PMID:21624456 |
| hydrazine | increases expression | EXP | | 6480464 | hydrazine results in increased expression of CYP17A1 mRNA | CTD | PMID:15370871 |
| lamotrigine | decreases activity | ISO | RGD:1350540 | 6480464 | lamotrigine results in decreased activity of CYP17A1 protein | CTD | PMID:15730543 |
| lead diacetate | increases expression | ISO | RGD:737222 | 6480464 | lead acetate results in increased expression of CYP17A1 mRNA | CTD | PMID:21335049 |
| levonorgestrel | multiple interactions | ISO | RGD:1350540 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA | CTD | PMID:19074003 |
| methotrexate | affects expression | ISO | RGD:737222 | 6480464 | Methotrexate affects the expression of CYP17A1 mRNA | CTD | PMID:18502557 |
| methoxychlor | multiple interactions | ISO | RGD:737222 | 6480464 | [Estradiol co-treated with Methoxychlor metabolite] results in decreased expression of CYP17A1 mRNA | CTD | PMID:11509743 |
| methoxychlor | decreases expression | ISO | RGD:737222 | 6480464 | Methoxychlor results in decreased expression of CYP17A1 mRNA | CTD | PMID:21514315 |
| methoxychlor | decreases expression | ISO | RGD:737222 | 6480464 | Methoxychlor metabolite results in decreased expression of CYP17A1 mRNA | CTD | PMID:11509743 |
| mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:16809437 |
| mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 protein | CTD | PMID:22087261 |
| mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA | CTD | PMID:16809437 PMID:22087261 |
| mono(2-ethylhexyl) phthalate | affects expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate affects the expression of CYP17A1 | CTD | PMID:19560483 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CYP17A1 mRNA | CTD | PMID:16809437 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CYP17A1 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [nodularin co-treated with Diethylnitrosamine] results in decreased activity of CYP17A1 protein | CTD | PMID:12112309 |
| N-nitrosodiethylamine | decreases activity | EXP | | 6480464 | Diethylnitrosamine results in decreased activity of CYP17A1 protein | CTD | PMID:12112309 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CYP17A1 mRNA | CTD | PMID:17072980 |
| oxycodone | affects expression | EXP | | 6480464 | Oxycodone affects the expression of CYP17A1 mRNA | CTD | PMID:20487198 |
| ozone | decreases expression | ISO | RGD:737222 | 6480464 | Ozone results in decreased expression of CYP17A1 mRNA | CTD | PMID:16183385 |
| paracetamol | multiple interactions | ISO | RGD:737222 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP17A1 mRNA] | CTD | PMID:17585979 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP17A1 mRNA | CTD | PMID:17202762 |
| paracetamol | affects expression | ISO | RGD:737222 | 6480464 | Acetaminophen affects the expression of CYP17A1 mRNA | CTD | PMID:17562736 |
| pentachlorophenol | decreases expression | ISO | RGD:1350540 | 6480464 | Pentachlorophenol results in decreased expression of CYP17A1 mRNA | CTD | PMID:21296122 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 PMID:16221955 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:16221955 more ... |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 more ... |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:18692542 more ... |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:16221955 PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:16221955 PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 PMID:16221955 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:737222 | 6480464 | perfluorooctanoic acid results in decreased expression of CYP17A1 mRNA | CTD | PMID:20118188 PMID:21712084 |
| perfluorooctanoic acid | increases expression | ISO | RGD:737222 | 6480464 | perfluorooctanoic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:737222 | 6480464 | perfluorooctanoic acid results in decreased expression of CYP17A1 mRNA | CTD | PMID:21712084 PMID:20118188 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:737222 | 6480464 | perfluorooctanoic acid results in decreased expression of CYP17A1 protein | CTD | PMID:21712084 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:737222 | 6480464 | [perfluorooctanoic acid co-treated with PPARA] results in increased expression of CYP17A1 mRNA | CTD | PMID:20118188 |
| phenobarbital | increases expression | ISO | RGD:737222 | 6480464 | Phenobarbital results in increased expression of CYP17A1 mRNA | CTD | PMID:19270015 |
| phenobarbital | increases expression | ISO | RGD:737222 | 6480464 | Phenobarbital results in increased expression of CYP17A1 mRNA | CTD | PMID:19270015 PMID:23091169 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 |
| pioglitazone | multiple interactions | ISO | RGD:1350540 | 6480464 | pioglitazone inhibits the reaction [PD 98059 results in increased expression of CYP17A1 mRNA]; more ... | CTD | PMID:17138841 |
| pioglitazone | decreases activity | ISO | RGD:1350540 | 6480464 | pioglitazone results in decreased activity of CYP17A1 protein | CTD | PMID:17138841 PMID:15072549 |
| pioglitazone | decreases expression | ISO | RGD:1350540 | 6480464 | pioglitazone results in decreased expression of CYP17A1 mRNA | CTD | PMID:17138841 |
| pioglitazone | decreases activity | ISO | RGD:1350540 | 6480464 | pioglitazone results in decreased activity of CYP17A1 protein | CTD | PMID:15072549 PMID:17138841 |
| piperonyl butoxide | decreases expression | EXP | | 6480464 | Piperonyl Butoxide results in decreased expression of CYP17A1 mRNA | CTD | PMID:22484513 |
| pirinixic acid | multiple interactions | ISO | RGD:737222 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CYP17A1 mRNA] | CTD | PMID:20059764 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid promotes the reaction [PPARA protein binds to CYP17A1 promoter] | CTD | PMID:23358192 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 PMID:22112501 |
| pirinixic acid | increases expression | ISO | RGD:737222 | 6480464 | pirinixic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:18301758 PMID:20059764 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:737222 | 6480464 | pirinixic acid results in increased expression of CYP17A1 mRNA | CTD | PMID:20059764 PMID:18301758 |
| pregnenolone | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein mutant form results in increased hydroxylation of Pregnenolone | CTD | PMID:15844475 |
| pregnenolone | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in increased hydroxylation of Pregnenolone | CTD | PMID:15844475 PMID:15562394 |
| pregnenolone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of Pregnenolone | CTD | PMID:16054388 PMID:16030167 |
| pregnenolone | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Pregnenolone binds to CYP17A1 protein] | CTD | PMID:15666820 |
| pregnenolone | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in increased hydroxylation of Pregnenolone | CTD | PMID:15562394 PMID:15844475 |
| pregnenolone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of Pregnenolone | CTD | PMID:16030167 PMID:16054388 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP17A1 mRNA | CTD | PMID:19162173 |
| profenofos | increases expression | EXP | | 6480464 | profenofos results in increased expression of CYP17A1 mRNA | CTD | PMID:17569032 |
| progesterone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of Progesterone | CTD | PMID:16054388 PMID:16030167 |
| progesterone | affects metabolic processing | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the metabolism of Progesterone | CTD | PMID:16030167 PMID:16054388 |
| progesterone | affects metabolic processing | EXP | | 6480464 | CYP17A1 protein affects the metabolism of Progesterone | CTD | PMID:15261307 |
| progesterone | increases hydroxylation | ISO | RGD:1350540 | 6480464 | CYP17A1 protein results in increased hydroxylation of Progesterone | CTD | PMID:15562394 |
| progesterone | multiple interactions | ISO | RGD:1350540 | 6480464 | CYP17A1 protein binds to and affects the metabolism of Progesterone | CTD | PMID:14522586 |
| pyruvic acid | multiple interactions | ISO | RGD:1350540 | 6480464 | Pyruvic Acid promotes the reaction [CTBP1 protein binds to CYP17A1 promoter]; more ... | CTD | PMID:18184656 |
| pyruvic acid | increases expression | ISO | RGD:1350540 | 6480464 | Pyruvic Acid results in increased expression of CYP17A1 mRNA | CTD | PMID:18184656 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[Atrazine co-treated with Bucladesine] results in increased expression of CYP17A1 mRNA]; more ... | CTD | PMID:23200735 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CYP17A1 mRNA | CTD | PMID:22719052 |
| rosiglitazone | decreases activity | ISO | RGD:1350540 | 6480464 | rosiglitazone results in decreased activity of CYP17A1 protein | CTD | PMID:15072549 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of CYP17A1 mRNA | CTD | PMID:21515302 |
| simvastatin | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of CYP17A1 mRNA]; more ... | CTD | PMID:21918126 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CYP17A1 mRNA | CTD | PMID:21918126 |
| sphingosine | increases expression | ISO | RGD:1350540 | 6480464 | Sphingosine results in increased expression of CYP17A1 mRNA | CTD | PMID:15666826 |
| sphingosine 1-phosphate | increases expression | ISO | RGD:1350540 | 6480464 | sphingosine 1-phosphate results in increased expression of CYP17A1 mRNA | CTD | PMID:15666826 |
| tamoxifen | increases response to substance | ISO | RGD:1350540 | 6480464 | CYP17A1 gene polymorphism results in increased susceptibility to Tamoxifen | CTD | PMID:15706422 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of CYP17A1 mRNA | CTD | PMID:17630414 |
| tamoxifen | affects expression | ISO | RGD:737222 | 6480464 | Tamoxifen affects the expression of CYP17A1 mRNA | CTD | PMID:20937368 |
| testosterone | affects abundance | ISO | RGD:1350540 | 6480464 | CYP17A1 protein affects the abundance of Testosterone | CTD | PMID:21427057 |
| testosterone | multiple interactions | ISO | RGD:737222 | 6480464 | Disulfiram inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased expression of CYP17A1 mRNA]; more ... | CTD | PMID:22285649 |
| testosterone | multiple interactions | EXP | | 6480464 | [prochloraz results in decreased activity of CYP17A1 protein] which results in decreased chemical synthesis of Testosterone | CTD | PMID:17369198 PMID:17234647 |
| testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A results in increased expression of CYP17A1 mRNA] which affects the abundance of Testosterone | CTD | PMID:18191889 |
| testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone | CTD | PMID:14605012 |
| testosterone | multiple interactions | EXP | | 6480464 | [prochloraz results in decreased activity of CYP17A1 protein] which results in decreased chemical synthesis of Testosterone | CTD | PMID:17234647 PMID:17369198 |
| testosterone | decreases expression | ISO | RGD:737222 | 6480464 | Testosterone results in decreased expression of CYP17A1 mRNA | CTD | PMID:20600201 PMID:21669218 |
| testosterone | multiple interactions | ISO | RGD:737222 | 6480464 | [Lipopolysaccharides results in decreased expression of CYP17A1 protein] which results in decreased abundance of Testosterone | CTD | PMID:8828518 |
| testosterone | affects chemical synthesis | ISO | RGD:737222 | 6480464 | CYP17A1 protein affects the chemical synthesis of Testosterone | CTD | PMID:15932923 |
| testosterone | multiple interactions | ISO | RGD:737222 | 6480464 | AMH protein inhibits the reaction [CYP17A1 protein affects the chemical synthesis of Testosterone] | CTD | PMID:14630719 |
| testosterone | decreases expression | ISO | RGD:1350540 | 6480464 | Testosterone results in decreased expression of CYP17A1 mRNA | CTD | PMID:15625562 |
| testosterone enanthate | multiple interactions | ISO | RGD:1350540 | 6480464 | [cetrorelix co-treated with testosterone enanthate] results in decreased expression of CYP17A1 mRNA; more ... | CTD | PMID:18160741 |
| testosterone enanthate | decreases expression | EXP | | 6480464 | testosterone enanthate results in decreased expression of CYP17A1 mRNA | CTD | PMID:21427060 |
| tetracycline | decreases expression | ISO | RGD:737222 | 6480464 | Tetracycline results in decreased expression of CYP17A1 mRNA | CTD | PMID:16917069 |
| tetraphene | increases expression | EXP | | 6480464 | benz(a)anthracene results in increased expression of CYP17A1 mRNA | CTD | PMID:23358148 |
| topiramate | decreases activity | ISO | RGD:1350540 | 6480464 | topiramate results in decreased activity of CYP17A1 protein | CTD | PMID:15730543 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CYP17A1 mRNA | CTD | PMID:22719052 |
| triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of CYP17A1 mRNA | CTD | PMID:19118620 |
| troglitazone | decreases activity | ISO | RGD:1350540 | 6480464 | troglitazone results in decreased activity of CYP17A1 protein | CTD | PMID:15072549 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CYP17A1 mRNA | CTD | PMID:21515302 |
| valproic acid | decreases expression | ISO | RGD:1350540 | 6480464 | Valproic Acid results in decreased expression of CYP17A1 mRNA | CTD | PMID:19566492 |
| valproic acid | increases expression | ISO | RGD:1350540 | 6480464 | Valproic Acid results in increased expression of CYP17A1 mRNA; more ... | CTD | PMID:14576182 |
| valproic acid | affects expression | ISO | RGD:737222 | 6480464 | Valproic Acid affects the expression of CYP17A1 mRNA | CTD | PMID:17292431 |